Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Ketamine Use in the Management of Upper Limb's Fracture Reduction in Pediatric Emergencies

NCT03525821 is registered in ClinicalTrials.gov with Fondation Lenval as lead sponsor.

NCT NCT03525821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03525821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Ketamine Use in the Management of Upper Limb's Fracture Reduction in Pediatric Emergencies
Lead sponsor
Fondation Lenval
Phase
Phase 3
Overall status
Completed
Start date
July 5, 2018
Completion date
September 13, 2020
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fractures, closed